Obi Pharma Stock Debt To Equity
| 4174 Stock | TWD 62.90 0.40 0.63% |
OBI Pharma fundamentals help investors to digest information that contributes to OBI Pharma's financial success or failures. It also enables traders to predict the movement of OBI Stock. The fundamental analysis module provides a way to measure OBI Pharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to OBI Pharma stock.
OBI |
OBI Pharma Company Debt To Equity Analysis
OBI Pharma's Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
Current OBI Pharma Debt To Equity | 0.06 % |
Most of OBI Pharma's fundamental indicators, such as Debt To Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, OBI Pharma is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.
| Competition |
According to the company disclosure, OBI Pharma has a Debt To Equity of 0.056%. This is 99.9% lower than that of the Healthcare sector and 99.71% lower than that of the Biotechnology industry. The debt to equity for all Taiwan stocks is 99.89% higher than that of the company.
OBI Debt To Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses OBI Pharma's direct or indirect competition against its Debt To Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of OBI Pharma could also be used in its relative valuation, which is a method of valuing OBI Pharma by comparing valuation metrics of similar companies.OBI Pharma is currently under evaluation in debt to equity category among its peers.
OBI Fundamentals
| Return On Equity | -0.34 | |||
| Return On Asset | -0.22 | |||
| Operating Margin | (311.15) % | |||
| Current Valuation | 12.29 B | |||
| Shares Outstanding | 228.95 M | |||
| Shares Owned By Insiders | 36.77 % | |||
| Shares Owned By Institutions | 5.00 % | |||
| Price To Book | 3.33 X | |||
| Price To Sales | 2,517 X | |||
| Revenue | 18.77 M | |||
| Gross Profit | (25.59 M) | |||
| EBITDA | (1.52 B) | |||
| Net Income | (1.53 B) | |||
| Cash And Equivalents | 3.57 B | |||
| Cash Per Share | 17.92 X | |||
| Total Debt | 28 M | |||
| Debt To Equity | 0.06 % | |||
| Current Ratio | 35.63 X | |||
| Book Value Per Share | 22.55 X | |||
| Cash Flow From Operations | (1.06 B) | |||
| Earnings Per Share | (8.05) X | |||
| Number Of Employees | 48 | |||
| Beta | 1.3 | |||
| Market Capitalization | 17.7 B | |||
| Total Asset | 4.49 B | |||
| Net Asset | 4.49 B |
About OBI Pharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze OBI Pharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of OBI Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of OBI Pharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with OBI Pharma
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if OBI Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OBI Pharma will appreciate offsetting losses from the drop in the long position's value.Moving together with OBI Stock
Moving against OBI Stock
| 0.89 | 2881A | Fubon Financial Holding | PairCorr |
| 0.85 | 2891 | CTBC Financial Holding | PairCorr |
| 0.84 | 2882B | Cathay Financial Holding | PairCorr |
| 0.79 | 2881B | Fubon Financial Holding | PairCorr |
| 0.78 | 2330 | Taiwan Semiconductor | PairCorr |
The ability to find closely correlated positions to OBI Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace OBI Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back OBI Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling OBI Pharma to buy it.
The correlation of OBI Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as OBI Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if OBI Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for OBI Pharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for OBI Stock Analysis
When running OBI Pharma's price analysis, check to measure OBI Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OBI Pharma is operating at the current time. Most of OBI Pharma's value examination focuses on studying past and present price action to predict the probability of OBI Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OBI Pharma's price. Additionally, you may evaluate how the addition of OBI Pharma to your portfolios can decrease your overall portfolio volatility.